Caffeine Completed Phase 4 Trials for Caffeine Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT01783561Early Versus Routine Caffeine Administration in Extremely Preterm Neonates